18:00 Fri 20 Nov 2020
City Pub Group (The) - Block Admission Six Monthly Return

The City Pub Group plc
("The City Pub Group" or the "Company")
Block Admission Six Monthly Return
The City Pub Group makes the following notification pursuant to AIM Rule 29 and Schedule 6 of the AIM Rules for Companies regarding its existing block admission announced on
The Company has allotted no further shares under the Block Admission.
Name of Company | The City Pub Group plc |
| |
Name of Scheme | The City Pub Group plc Company Share Option Plan 2016 |
| |
Period of Return (from / to) | |
| |
Number and class of securities not issued at the start of the period under the scheme | 690,000 Ordinary Shares |
| |
Number of securities issued under the scheme during the period | None |
| |
Balance under the scheme of securities not yet issued at the end of the period | 690,000 Ordinary Shares |
| |
Number and class of securities originally admitted and the date of admission | 952,500 Ordinary Shares admitted on |
| |
Name of contact and telephone number | Tel: +44 (0) 20 7457 2020 |
| |
Enquiries: | | ||
City Pub Group Clive Watson, Chairman Tarquin Williams, CFO | | ||
| | ||
Instinctif Partners Matthew Smallwood Jack Devoy | +44 (0) 20 7457 2020 | ||
| | ||
Liberum (Nomad & Broker) Chris Clarke Edward Thomas Clayton Bush | +44 (0) 20 3100 2000 | ||
| | ||
For further information on City Pub Group pubs visit www.citypubcompany.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
FOR OUR FULL DISCLAIMER CLICK HERE